Atlas Trials

Local Control With Reduced-dose Radiotherapy for High-Risk Neuroblastoma

Clinical trial NCT02245997 · COMPLETED

Trial details

NCT number
NCT02245997
Sponsor
Memorial Sloan Kettering Cancer Center
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Neuroblastoma
Start date
2014-09-01
Primary completion
2025-05-01
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.